GFAP and Parkinson disease: Despite no significant alterations in the number of mature astrocytes (GFAP&S100B double-positive cells) between PD and WT conditions from day 30 onwards (Fig. 1e), changes in GFAP and S100B protein levels were detected (Fig. 1f, g).